🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
iX Biopharma Ltd. (SGX:42C)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.4550
0.00 (0.00%)
At close: Nov 18, 2026

iX Biopharma Income Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
7.966.857.775.965.9114.39
Revenue Growth
6.17%-11.77%30.34%0.78%-58.91%724.64%
Cost of Revenue
4.264.425.734.913.592.1
Gross Profit
3.72.432.041.052.3212.29
Selling, General & Admin
11.159.456.696.719.049.46
Research & Development
3.952.491.641.732.822.33
Operating Expenses
15.16128.338.5411.8611.79
Operating Income
-11.46-9.56-6.29-7.5-9.540.5
Interest Expense
-0.65-0.69-0.33-0.44-0.27-0.2
Interest & Investment Income
0.010.010.020.030.01-
Currency Exchange Gain (Loss)
2.552.55-3.40.08-2.77-1.91
Other Non Operating Income (Expenses)
-0.94-0.03-0.140.351.120.74
EBT Excluding Unusual Items
-10.49-7.72-10.14-7.47-11.46-0.88
Impairment of Goodwill
-0.29-0.29----
Gain (Loss) on Sale of Investments
0.040.04-0.01-2.511.74-3.26
Gain (Loss) on Sale of Assets
0.060.06----
Asset Writedown
-0.08-0.08----
Other Unusual Items
----0.010.04
Pretax Income
-10.75-7.98-10.14-9.99-9.71-4.1
Income Tax Expense
0.010.0100.81-0.090.5
Earnings From Continuing Operations
-10.76-7.99-10.14-10.79-9.62-4.6
Net Income
-10.76-7.99-10.14-10.79-9.62-4.6
Net Income to Common
-10.76-7.99-10.14-10.79-9.62-4.6
Net Income Growth
------
Shares Outstanding (Basic)
996965877767765746
Shares Outstanding (Diluted)
996965877767765746
Shares Change
12.37%10.08%14.25%0.33%2.51%7.60%
EPS (Basic)
-0.01-0.01-0.01-0.01-0.01-0.01
EPS (Diluted)
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-9.93-7.62-3.96-6.83-8.362.92
Free Cash Flow Per Share
-0.01-0.01-0.01-0.01-0.010.00
Gross Margin
46.48%35.52%26.27%17.59%39.24%85.41%
Operating Margin
-143.89%-139.52%-80.92%-125.78%-161.41%3.48%
Profit Margin
-135.10%-116.64%-130.56%-181.14%-162.61%-31.95%
Free Cash Flow Margin
-124.73%-111.21%-50.97%-114.57%-141.30%20.31%
EBITDA
-11.12-9.19-5.87-7.08-9.041.15
EBITDA Margin
-139.67%-134.10%-75.59%-118.88%-152.93%7.99%
D&A For EBITDA
0.340.370.410.410.50.65
EBIT
-11.46-9.56-6.29-7.5-9.540.5
EBIT Margin
-143.89%-139.51%-80.92%-125.78%-161.41%3.48%